Amygdala and Insula Retraining Tied to Reduction in Fatigue With Long COVID
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, July 24, 2023 -- Amygdala and insula retraining (AIR), a neuroplasticity program, may be a viable means of reducing fatigue and increasing energy among patients with long COVID, according to a study published online July 17 in the Evidence-Based Complementary and Alternative Medicine Journal.
Loren L. Toussaint, Ph.D., from Luther College in Decorah, Iowa, and Alexandra J. Bratty, M.B.A., Ph.D., from AB Research Consulting in Las Vegas, randomly assigned 100 participants (aged 21 to 65 years) with postviral symptoms at least three months after an acute COVID-19 infection to AIR or control.
The researchers found a significant decrease in participants' fatigue and a significant increase in their energy after the three-month AIR intervention. Fatigue reduction was nearly four times higher in the AIR group versus the control group, while the absolute reduction in mean scores for the AIR group was more than double that of the control group. Similarly, the effect size in energy enhancement among AIR participants was twice that of the control group, and the absolute increase in energy mean scores for the AIR group was almost double that of the control group.
"These findings are both timely and pertinent, as so little is known about how to treat long COVID and so many patients suffer from it after the acute infection of COVID-19," the authors write.
Bratty is the CEO of AB Research Consulting, which provides consulting services to The Gupta Program, the commercial version of the AIR intervention; Bratty's company was compensated for this work by independent donors.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Further Support and Information on COVID-19
Read this next
Mortality Higher for COVID-19 Hospitalization Than for Flu in 2023/2024 Season
WEDNESDAY, May 22, 2024 -- In fall/winter 2023/2024, the risk for death in patients hospitalized for COVID-19 was greater than the risk for death in patients hospitalized for...
Global Life Expectancy, Disease Burden Set to Keep Improving
WEDNESDAY, May 22, 2024 -- Life expectancy and age-standardized disease burden are expected to continue improving between 2022 and 2050, according to the Global Burden of Disease...
Sleep Restriction Tied to Negative Cognitive Effects in Teens With Overweight, Obesity
WEDNESDAY, May 22, 2024 -- Adolescents with overweight or obesity may be more vulnerable to negative cognitive effects following sleep restriction, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.